Pharma wants Canberra to get "back to business"
This article was originally published in Scrip
Executive Summary
Innovator pharmaceutical companies are calling on Australia's new Labor minority government to get "back to business" and pursue previously agreed measures designed to provide pricing stability as well as speeding up reimbursement decisions on new but expensive drugs through the state-backed Pharmaceutical Benefits Scheme (PBS).